fbpx

Male, 75 y/o

Patient internal ID: 58261933

ICD-10 code

C61 Malignant Neoplasm of Prostate

Diagnosis (incl metastases/stage) and year

March 2019
Prostate Carcinoma cT4N0M1 (Gleason 5+5=10) stage IV. Multiple Bone Metastases.

Previous treatment

Surgery (Prostatectomy), Hormone Therapy (Bicalutamide), Radiation Therapy, Hormone Therapy (Abiraterone).

Prognosis and survival expectation

The prognosis remains poor, Prostate Cancer with distant Metastasis has a 5-year survival rate of close to 30%. Median survival of ~42 months from diagnosis.

Treatment provided

Autologous DCV (2 doses) over a period of 1 month.

Patient survival/condition and year

The patient had survived for 11 years since the diagnosis and 4,5 years since the disease progression. Patient received only 2 doses of Immunotherapy at the end of his life, no conclusions can be made.

Date of Review

01/01/2024